Beauty and Cosmetics Industry Awards 2025 International Design Competition for Beauty and Personal Care Products Accepting Last Submissions ...

Scientific Awards Unveils Comprehensive A' Design Prize Package Celebrating Excellence in Natural Sciences and Mathe ...

Intensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and development of proprietary, novel immune-based ...

"This is a historic moment for 4DMT as we become a Phase 3 company following our initiation of the 4FRONT-1 clinical trial,” said David Kirn, M.D., Co-founder and Chief Executive Officer of 4DMT.

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted ...

The invention features a novel and eye-catching design and it could incorporate logos, branding ... pharmaceuticals, and biotechnology research. With a compound annual growth rate (CAGR) of 6.6%, the ...

Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of therapies for ...

Organizations can deploy OCI's 150+ AI and cloud services with NVIDIA accelerated computing and NVIDIA AI Enterprise in their data center, the public cloud, or at the edge. This offering provides an ...

Datavault® AI (NASDAQ: DVLT), formerly known as WiSA Technologies, Inc., is pleased to announce that Optoma's HCPro-4400 4K UHD DLP® laser projector has received WiSA SoundSend Certification. This ...

Detailed price information for 4D Molecular Therapeutics Inc (FDMT-Q) from The Globe and Mail including charting and trades.